期刊文献+

人前心钠肽在血液细菌感染患者中的应用 被引量:2

The value of pro-atrial natriuretic peptide in patients with bacteremia
下载PDF
导出
摘要 目的:检测血液细菌培养阳性患者血清中人前心钠肽(proANP)水平,与人前降钙素(PCT)水平进行比较,评价proANP在菌血症或败血症患者中的诊断价值。方法:收集我院住院或门诊送检的血液需氧菌培养为阳性的患者血清43例作为观察组,选择12例健康成人血清作对照组,同时做proANP和PCT检测。结果:proANP和PCT两组比较差异有显著性。两指标呈正相关(y = 28.009 + 9.732x, r = 0.954, P <0.001)。结论:proANP对菌血症或败血症患者的早期快速诊断与PCT具有相似的价值并呈正相关。 Objective To compare the levels of pro-atrial natriuretic peptide (proANP) and procacitonin (PCT) in patients with bacteremia or septicemia,and to evaluate the diagnostic value of proANP for them.Methods Fourty-three blood samples with positive aerobic germiculture were collect as patient group,12 blood samples from healthy adult as control group.The levels of proANP and PCT were measured.Results In patient group,the relation between proANP and PCT could be described as y=28.009 + 9.732x,r=0.954,P 0.001.Conclusion The value of proANP for early and rapid diagnosis of patients with bacteremia or septicemia was similar to that of PCT,and they were positively correlated.
出处 《实用医学杂志》 CAS 北大核心 2011年第19期3513-3514,共2页 The Journal of Practical Medicine
基金 遵义市红花岗区科学技术资金支助项目[编号:遵红科合 科 字(2008)22 号]
关键词 细菌感染 人前心钠肽 人前降钙素 血细菌培养阳性 Bacterial infections Pro-atrial natriuretic peptide Procacitonin Blood germiculture positive
  • 相关文献

参考文献11

二级参考文献28

共引文献172

同被引文献21

  • 1田海皊,胡大一.利钠多肽对慢性心力衰竭伴睡眠呼吸暂停患者心功能的评价[J].中华老年医学杂志,2006,25(8):570-573. 被引量:2
  • 2《抗菌药物临床应用管理办法》(卫生部令第84号).中华人民共和国卫生部.2012.
  • 3Pulido L, Ghanem E, Joshi A,et al. Periprosthetic jointinfection : the incidence, timing, and predisposing factors [ J].Clin Orthop Relat Res,2008,466(7) : 1710-1715.
  • 4Mangram AJ, Horan TC , Pearson ML,et al. Guideline forprevention of surgical site infection [J]. Infect Control HospEpidemiol, 1999,20(4) :247-264.
  • 5Choong PF, Dowsey MM , Carr D, et al. Risk factors associatedwith acute hip prosthetic joint infections and outcome oftreatment with a rifampin-based regimen [J]. Acta Orthop,2007,78(6):755-765.
  • 6Pulido L, Ghanem E, Joshi A,et al. Periprosthetic jointinfection: the incidence, timing,and predisposing factors [J],Clin Orthop Relat Res’2008,466(7) : 1710-1715.
  • 7Pedersen AB, Svendsson JE,Johnsen SP,et al. Risk factors forrevision due to infection after primary total hip arthroplasty. Apopulation-based study of 80,756 primary procedures in theDanish Hip Arthroplasty Registry [J]. Acta Orthop 2010,81(5): 542-547.
  • 8Al Buhairan B, Hind D, Hutchinson A. Antibiotic prophylaxisfor wound infections in total joint arthroplasty : A systemicReview [J]. J Bone Joint Surg Br,2008,90(7) :915-919.
  • 9Gyssens IC. Preventing postoperative infections:current treatmentrecommendations [J]. Drugs, 1999,57(2) : 175-185.
  • 10Galandiuk S, Polk HC Jr, Jagelman DG, et al. Re-emphasis ofpriorities in surgical antibiotic prophylaxis [J]. Surg GynecolObstet,1989,169(3): 219-222.

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部